Market revenue in 2023 | USD 1.4 million |
Market revenue in 2030 | USD 2.3 million |
Growth rate | 7.7% (CAGR from 2023 to 2030) |
Largest segment | Human donor tissue-derived products |
Fastest growing segment | Acellular Animal-derived Products |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Human Donor Tissue-Derived Products, Acellular Animal-derived Products |
Key market players worldwide | 3M Co, Organogenesis Holdings Inc Class A, Integra Lifesciences Holdings Corp, Smith & Nephew PLC, MiMedx Group Inc, Essity AB Class B, Stryker Corp, Vericel Corp, Mallinckrodt PLC Ordinary Shares - New, Tissue Regenix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biological skin substitutes market will help companies and investors design strategic landscapes.
Human donor tissue-derived products was the largest segment with a revenue share of 64.29% in 2023. Horizon Databook has segmented the Argentina biological skin substitutes market based on human donor tissue-derived products, acellular animal-derived products covering the revenue growth of each sub-segment from 2018 to 2030.
Argentina is one of the most advanced Latin American countries in terms of regulatory legislation. It is a lucrative market for contract research, owing to its favorable regulatory guidelines, cost compliance, and established clinical infrastructure.
The country has aligned its regulations on clinical research with international standards & requirements, which enable laboratories to conduct clinical trials for big medical device companies from developed economies.
It is expected that medical device companies may begin outsourcing clinical trials to Argentina to take advantage of cost-effectiveness, time-saving, & expertise while maintaining compliance with international standards such as the Good Clinical Practices & Good Laboratory Practices.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina biological skin substitutes market , including forecasts for subscribers. This country databook contains high-level insights into Argentina biological skin substitutes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account